SMS Pharmaceuticals
SMSPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Ramesh Babu · MD: Ramesh Babu · Listing date: Feb. 28, 2007 · Employees: 1080 · Hyderabad · http://www.smspharma.com

Stock Price vs Company Growth
1d
3.5%
1w
6.4%
1m
16.4%
3m
3.2%
6m
45.7%
1y
154.7%
5y
50.1%
10y
20.0%
all
13.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 305 3.5%
274
398
Company Overview

Sales
738 Cr
Growth: 31.4%
Profit after Tax
57 Cr
Growth: 14.3%
Small Cap
2,582 Cr
P/E: 45.3x
Industry P/E: 41.5x
Fundamentals

Sales (Cr) ₹ 738
Growth 31.4%
EBITDA 16.8%
P/S 3.5x
Dividend 0.2%
P/E 45.3x
Book Value ₹ 65.3
PEG Ratio 1.4x
ROE 11.0%
P/B 4.5x
Shareholding Pattern

Institutions
Venkata Subbaraju Penmatsa .
2.13 %
Vivek Mundra
1.23 %
Aniruddh Mundra
1.13 %
Madhusudan Murlidhar Kela
1.1 %
Iepf
0.07 %
Promoters
Ramesh Babu Potluri
18.37 %
Hima Bindu Potluri
17.47 %
Vamsi Krishna Potluri
15.74 %
Potluri Infra Projects Llp
8.68 %
Trilok Potluri
2.58 %
Others
Increase    Decrease    No change
Company Profile Detailed

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi location group having product list spreading across an array of therapeutic segments. SMS is currently a listed company having ever appreciating international and domestic customer base.
Investors (45)